Melanoma Support Group Now Available in Fridley

Minnesota Oncology, in collaboration with the Virginia Piper Cancer Institute, is now offering a new monthly support group for people diagnosed with melanoma. The group will be facilitated by healthcare professionals currently working directly with melanoma patients in our clinics. The group is primarily for patients with stage III and IV melanoma and their families/support people, but everyone is welcome.

“We want to give patients and caregivers a place to share concerns as they cope with cancer and in so doing, realize they are not alone,” said Minnesota Oncology nurse Linda Clementi. “This is an opportunity to make connections with people sharing the same diagnosis,” she said. “We hope it will be a place to gain knowledge, inspiration, and methods to better cope with the physical and emotional impact of melanoma.”

  [Support Group]

The group will meet the first Tuesday of every month from 7-8:30 p.m. The first meeting is planned for Tuesday, June 3, in the Virginia Piper Cancer Institute conference room on the second floor of the Fridley Medical Center. There is no cost and registration is not required.

Suggestions on format and topics are welcome and encouraged. Please contact Linda Clementi, RN, BSN, OCN at (763) 252-1767 with your input or questions.

Share

Categories

Tags

Recent Posts

#
September 28, 2026

Learn about the common signs and symptoms of lymphoma and leukemia, including fatigue, swollen lymph nodes, unexplained bruising, frequent infections, fever, and other changes that may warrant medical evaluation.

#
September 23, 2026

Learn about thyroid cancer, including common signs and symptoms, risk factors, and treatment options. Learn when to talk with your doctor about concerning symptoms.

#
September 17, 2026

Julie Sowles shares her journey with Stage IV endometrial cancer, from her initial diagnosis and intensive treatment to recurrence and participation in clinical trials. With the support of her family and care team at Minnesota Oncology, Julie continues exploring new treatment options and looking toward the future with hope.